Raras
Buscar doenças, sintomas, genes...
Defeito no complexo de Golgi oligomérico conservado
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

O complexo oligomérico de Golgi conservado, também conhecido como complexo COG, é uma proteína de membrana extrínseca encontrada no aparelho de Golgi em eucariotos. Este complexo é conservado evolutivamente e possui subunidades homólogas encontradas em todas as espécies de eucariotos. O complexo COG foi descoberto pela primeira vez em 1981 em células de ovário de hamster chinês. Essas células de ovário apresentavam mutações nos receptores de lipoproteína de baixa densidade (LDL), o que afetava a função das enzimas de glicosilação do Golgi. No entanto, o complexo COG como um todo não foi totalmente compreendido até 2004, quando uma deficiência em uma das subunidades do COG foi associada a distúrbios congênitos da glicosilação. Essas descobertas levaram à percepção de que o complexo COG desempenha um papel importante na glicosilação e na classificação de proteínas.

🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
44 sintomas
🦴
Ossos e articulações
27 sintomas
😀
Face
23 sintomas
🫃
Digestivo
16 sintomas
📏
Crescimento
12 sintomas
❤️
Coração
9 sintomas

+ 84 sintomas em outras categorias

Características mais comuns

Sequência de Pierre-Robin
Dificuldades alimentares
Anormalidade da cascata de coagulação
Agenesia do vermis cerebelar
Sepse neonatal
Teto acetabular plano
262sintomas
Sem dados (262)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 262 características clínicas mais associadas, ordenadas por frequência.

Sequência de Pierre-RobinPierre-Robin sequence
Dificuldades alimentaresFeeding difficulties
Anormalidade da cascata de coagulaçãoAbnormality of the coagulation cascade
Agenesia do vermis cerebelarAgenesis of cerebellar vermis
Sepse neonatalNeonatal sepsis

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa11
Últimos 10 anos43publicações
Pico20218 papers
Linha do tempo
20202015Hoje · 2026📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

7 genes identificados com associação a esta condição.

COG5Conserved oligomeric Golgi complex subunit 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi function

LOCALIZAÇÃO

Cytoplasm, cytosolGolgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2I

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments.

OUTRAS DOENÇAS (1)
COG5-congenital disorder of glycosylation
HGNC:14857UniProt:Q9UP83
COG4Conserved oligomeric Golgi complex subunit 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi function (PubMed:19536132, PubMed:30290151). Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with SCFD1 (PubMed:19536132)

LOCALIZAÇÃO

Cytoplasm, cytosolGolgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2J

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (2)
microcephalic osteodysplastic dysplasia, Saul-Wilson typeCOG4-congenital disorder of glycosylation
HGNC:18620UniProt:Q9H9E3
COG8Conserved oligomeric Golgi complex subunit 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi function

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2H

CDGs are a family of severe inherited diseases caused by a defect in protein N-glycosylation. They are characterized by under-glycosylated serum proteins. These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
COG8-congenital disorder of glycosylation
HGNC:18623UniProt:Q96MW5
COG7Conserved oligomeric Golgi complex subunit 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi function

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2E

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (1)
COG7-congenital disorder of glycosylation
HGNC:18622UniProt:P83436
COG6Conserved oligomeric Golgi complex subunit 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi function

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2L

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Clinical features of CDG2L include neonatal intractable focal seizures, vomiting, loss of consciousness, intracranial bleeding due to vitamin K deficiency, and death in infancy.

OUTRAS DOENÇAS (2)
hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndromeCOG6-congenital disorder of glycosylation
HGNC:18621UniProt:Q9Y2V7
COG2Conserved oligomeric Golgi complex subunit 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi morphology and function

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2Q

A form of congenital disorder of glycosylation, a genetically heterogeneous group of autosomal recessive, multisystem disorders caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. The transmission pattern of CDG2Q is consistent with autosomal recessive inheritance.

OUTRAS DOENÇAS (1)
congenital disorder of glycosylation, type IIq
HGNC:6546UniProt:Q14746
COG1Conserved oligomeric Golgi complex subunit 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal Golgi function

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportIntra-Golgi traffic
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2G

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Clinical features of CDG2G include failure to thrive, generalized hypotonia, growth retardation and mild psychomotor retardation. CDG2G is biochemically characterized by a defect in O-glycosylation as well as N-glycosylation.

OUTRAS DOENÇAS (1)
COG1-congenital disorder of glycosylation
HGNC:6545UniProt:Q8WTW3

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Levocarnitine (LEVOCARNITINE)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

311 variantes patogênicas registradas no ClinVar.

🧬 COG5: NM_006348.5(COG5):c.2393_2397del (p.Tyr798fs) ()
🧬 COG5: NM_006348.5(COG5):c.872A>T (p.Asn291Ile) ()
🧬 COG5: NM_006348.5(COG5):c.94+3A>T ()
🧬 COG5: NM_006348.5(COG5):c.539-93G>T ()
🧬 COG5: NM_006348.5(COG5):c.539-81T>G ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Defeito no complexo de Golgi oligomérico conservado

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function.

PLoS genetics2026 Mar

COG5, a subunit of the conserved oligomeric Golgi (COG) complex, plays a critical role in retrograde trafficking within the Golgi apparatus. Dysfunction of COG5 is associated with various human disorders, yet the underlying pathogenic mechanisms remain poorly understood. To investigate the mechanisms, we conducted proteomic analyses using COG5-deficient and rescue cell models, which revealed a potential link between COG5 dysfunction and mitochondrial oxidative phosphorylation (OXPHOS) deficiency. Using COG5-deficient cell models and patient-derived cells harboring COG5 variants, we biochemically validated the involvement of COG5 in mitochondrial OXPHOS, particularly in the regulation of complex I content. These models also exhibited elevated cellular copper levels. Notably, the significant reduction in OXPHOS complexes could be rescued by either restoring COG5 expression or administering a copper chelator. We further demonstrated that excessive cellular copper disrupts the function of mitochondrial iron-sulfur clusters, potentially leading to complex I assembly defects. Additionally, we identified a patient with biallelic COG5 variants presenting with a distinct subtype of mitochondrial disease (Leigh syndrome), a phenotype not previously associated with COG5-related disorders. These findings provide novel mechanistic insights into the role of COG5, extending beyond its established function in Golgi-mediated glycosylation modifications. Our results underscore the importance of COG5 in mitochondrial function through a copper-dependent pathway, offering new perspectives on its contribution to cellular homeostasis and disease pathogenesis.

#2

The COG3 subunit interacts with SNX1 to enhance salt tolerance in Arabidopsis.

Plant physiology and biochemistry : PPB2026 Feb

Salt stress severely restricts plant growth and agricultural productivity. The Conserved Oligomeric Golgi complex (COG) plays a key role in vesicular trafficking, but its function in plant stress responses remains poorly understood. Here, we demonstrated that the expression of the subunit COG3 of the COG complex in Arabidopsis thaliana was significantly induced under salt stress. The COG3 knockdown mutant (cog3) exhibits severe growth and development defects, as well as high sensitivity to salt stress. Furthermore, genetic complementation with COG3-GFP partially rescued the salt-sensitive phenotype of the cog3 mutant, while overexpression of COG3 enhanced plant salt tolerance. Mechanistically, COG3 physically interacts with the Sorting Nexin 1 (SNX1) on the endosome, and genetic evidence indicates that COG3 acts upstream of SNX1. We propose that under salt stress, COG3 maintains Golgi structural integrity and stabilizes SNX1 protein, thereby facilitating SNX1-mediated recycling of cargo proteins from endosomes to the plasma membrane to maintain cellular ion homeostasis. Loss of COG3 function disrupts this recycling pathway, leading to salt hypersensitivity. Our study reveals a novel COG3-SNX1 regulatory module that mediates protein recycling to enhance salt tolerance, providing new insights into the molecular mechanisms underlying plant adaptation to abiotic stress.

#3

Identification of an ERGIC-Like Compartment in Fission Yeast: Emp43 Functions as a Lectin-Like Cargo Receptor for Glycosylated Proteins.

Molecular microbiology2026 Jan

The endoplasmic reticulum-Golgi intermediate compartment (ERGIC) plays a crucial role in the secretory pathway; however, its existence and function in lower eukaryotes remain largely unexamined. In this study, we identified Emp43 (SPBC4F6.05c) of Schizosaccharomyces pombe, an orthologue of human (Homo sapiens) ERGIC-53, and demonstrated its localization to an ERGIC-like compartment. The localization of Emp43 depended on its C-terminal KYL motif and oligomerization through the CC1 domain. Deletion of S. pombe emp43+ resulted in significant sensitivity to MgCl2 and FK506, along with defects in septum integrity, indicating a role in cell wall maintenance. Further analysis identified Ssp120 of S. pombe, an orthologue of human MCFD2, as a functional partner of Emp43. Yeast two-hybrid assays confirmed a strong interaction between Emp43 and Ssp120, and both proteins co-localized within an ERGIC-like compartment. Additionally, we identified Meu17 of S. pombe, a glucan-α-1,4-glucosidase homolog, as a potential ligand for Emp43. Overexpression of Meu17 rescued MgCl2 sensitivity in both emp43Δ and ssp120Δ strains, while mutations in its N-linked glycosylation sites (N383, N409) or its predicted active site (D203) disrupted its septum localization and functional rescue capability. Our findings indicate that Emp43 forms a complex with Ssp120 to facilitate the transport of glycosylated proteins, such as Meu17, within an ERGIC-like compartment in fission yeast S. pombe. This study provides the first evidence of an ERGIC-like structure in S. pombe and highlights the conserved nature of ERGIC-associated mechanisms across eukaryotes.

#4

Killer toxin K28 resistance in yeast relies on COG complex-mediated trafficking of the defence factor Ktd1.

Journal of cell science2025 Jul 15

AB toxins are a diverse family of protein toxins that enter host cells via endocytosis and induce cell death. In yeast, the AB toxin K28 is internalised to endosomes of susceptible yeast, before following the retrograde trafficking pathway and ultimately triggering cell cycle arrest. The endolysosomal defence factor Ktd1 protects against K28, but its regulation remains unclear. We show all lobe B subunits of the conserved oligomeric Golgi (COG) tethering complex are required for K28 resistance. Our experiments suggest the hypersensitivity of cog mutants is primarily explained by defects in Ktd1 trafficking. Ktd1 mis-localisation in cog mutants is reminiscent of disruptions in Snc1, a surface cargo that recycles multiple times via the Golgi. This work suggests not only that the COG complex is responsible for the precise trafficking of Ktd1 required to mediate toxin defence, but that Ktd1 might survey endolysosomal compartments for toxin. This work underpins the importance of Ktd1 in defence against the AB toxin K28, and implies how various membrane trafficking regulators could influence toxin effects in other eukaryotic systems.

#5

Deep proteomic profiling of the intra-Golgi trafficking intermediates.

Molecular biology of the cell2025 Jul 01

Intracellular trafficking relies on small membrane intermediates that transport cargo between different compartments. However, the precise role of vesicles in preserving Golgi function remains uncertain. To clarify this, we induced acute inactivation of the Conserved Oligomeric Golgi (COG) complex and analyzed vesicles from the different Golgi compartments. Proteomic analysis of the resulting vesicles revealed distinct molecular profiles, indicating a robust recycling system for Golgi proteins. All glycosylation enzymes and sugar transporters were detected in immunoisolated vesicles. The abundance of glycosylation machinery in intra-Golgi vesicles significantly increased following acute COG malfunction. Vesicles isolated from wild-type cells retained various vesicular coats, which were detaching from COG complex-dependent (CCD) vesicles stalled in the untethered state. Additionally, COG depletion led to increased molecular overlap among different populations of vesicles, suggesting that defects in vesicle tethering disrupt intra-Golgi sorting. Notably, CCD vesicles were functional and could be specifically rerouted to mitochondria that ectopically express Golgi tethers. Our findings demonstrate that the entire Golgi glycosylation machinery recycles within vesicles in a COG-dependent manner, whereas secretory and ER-Golgi trafficking proteins were not enriched. These results support a model in which the COG complex orchestrates the multistep recycling of glycosylation machinery, coordinated by specific coats, tethers, and SNAREs.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 43

2026

COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function.

PLoS genetics
2026

The COG3 subunit interacts with SNX1 to enhance salt tolerance in Arabidopsis.

Plant physiology and biochemistry : PPB
2026

Identification of an ERGIC-Like Compartment in Fission Yeast: Emp43 Functions as a Lectin-Like Cargo Receptor for Glycosylated Proteins.

Molecular microbiology
2025

Killer toxin K28 resistance in yeast relies on COG complex-mediated trafficking of the defence factor Ktd1.

Journal of cell science
2025

Deep proteomic profiling of the intra-Golgi trafficking intermediates.

Molecular biology of the cell
2024

Comprehensive Proteomic Characterization of the Intra-Golgi Trafficking Intermediates.

bioRxiv : the preprint server for biology
2024

Characterization and functional analysis of Toxoplasma Golgi-associated proteins identified by proximity labeling.

mBio
2023

Syntaxin-5's flexibility in SNARE pairing supports Golgi functions.

Traffic (Copenhagen, Denmark)
2023

Rapid COG Depletion in Mammalian Cell by Auxin-Inducible Degradation System.

Methods in molecular biology (Clifton, N.J.)
2023

Acute COG complex inactivation unveiled its immediate impact on Golgi and illuminated the nature of intra-Golgi recycling vesicles.

Traffic (Copenhagen, Denmark)
2022

COG6-CDG: Novel variants and novel malformation.

Birth defects research
2021

Development and Initial Characterization of Cellular Models for COG Complex-Related CDG-II Diseases.

Frontiers in genetics
2021

A Dominant Heterozygous Mutation in COG4 Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling.

Frontiers in cell and developmental biology
2021

Genetic analysis and prenatal diagnosis in a Chinese with growth retardation, abnormal liver function, and microcephaly.

Molecular genetics & genomic medicine
2021

Proteoglycan synthesis in conserved oligomeric Golgi subunit deficient HEK293T cells is affected differently, depending on the lacking subunit.

Traffic (Copenhagen, Denmark)
2021

COG1-congenital disorders of glycosylation: Milder presentation and review.

Clinical genetics
2021

Saul-Wilson Syndrome Missense Allele Does Not Show Obvious Golgi Defects in a C. elegans Model.

microPublication biology
2021

Syntaxin of plants31 (SYP31) and SYP32 is essential for Golgi morphology maintenance and pollen development.

Plant physiology
2021

Disorder of sex development associated with a novel homozygous nonsense mutation in COG6 expands the phenotypic spectrum of COG6-CDG.

American journal of medical genetics. Part A
2020

Golgi inCOGnito: From vesicle tethering to human disease.

Biochimica et biophysica acta. General subjects
2020

Sugary Logistics Gone Wrong: Membrane Trafficking and Congenital Disorders of Glycosylation.

International journal of molecular sciences
2020

Arabidopsis COG6 is essential for pollen tube growth and Golgi structure maintenance.

Biochemical and biophysical research communications
2019

Maintaining order: COG complex controls Golgi trafficking, processing, and sorting.

FEBS letters
2019

Defects in COG-Mediated Golgi Trafficking Alter Endo-Lysosomal System in Human Cells.

Frontiers in cell and developmental biology
2018

A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation.

American journal of human genetics
2018

Defective mucin-type glycosylation on α-dystroglycan in COG-deficient cells increases its susceptibility to bacterial proteases.

The Journal of biological chemistry
2018

Detailed Analysis of the Interaction of Yeast COG Complex.

Cell structure and function
2018

More than just sugars: Conserved oligomeric Golgi complex deficiency causes glycosylation-independent cellular defects.

Traffic (Copenhagen, Denmark)
2018

Conserved Oligomeric Golgi and Neuronal Vesicular Trafficking.

Handbook of experimental pharmacology
2017

A Mild Form of COG5 Defect Showing Early-Childhood-Onset Friedreich's-Ataxia-Like Phenotypes with Isolated Cerebellar Atrophy.

Journal of Korean medical science
2017

COG7 deficiency in Drosophila generates multifaceted developmental, behavioral and protein glycosylation phenotypes.

Journal of cell science
2018

Hypothesis: lobe A (COG1-4)-CDG causes a more severe phenotype than lobe B (COG5-8)-CDG.

Journal of medical genetics
2017

The Golgin protein Coy1 functions in intra-Golgi retrograde transport and interacts with the COG complex and Golgi SNAREs.

Molecular biology of the cell
2017

The Arl3 and Arl1 GTPases co-operate with Cog8 to regulate selective autophagy via Atg9 trafficking.

Traffic (Copenhagen, Denmark)
2017

MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.

Journal of mass spectrometry : JMS
2016

Creating Knockouts of Conserved Oligomeric Golgi Complex Subunits Using CRISPR-Mediated Gene Editing Paired with a Selection Strategy Based on Glycosylation Defects Associated with Impaired COG Complex Function.

Methods in molecular biology (Clifton, N.J.)
2016

The role of acroblast formation during Drosophila spermatogenesis.

Biology open
2016

Arabidopsis COG Complex Subunits COG3 and COG8 Modulate Golgi Morphology, Vesicle Trafficking Homeostasis and Are Essential for Pollen Tube Growth.

PLoS genetics
2016

COG lobe B sub-complex engages v-SNARE GS15 and functions via regulated interaction with lobe A sub-complex.

Scientific reports
2016

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.

Molecular genetics and metabolism reports
2016

COG Complex Complexities: Detailed Characterization of a Complete Set of HEK293T Cells Lacking Individual COG Subunits.

Frontiers in cell and developmental biology
2015

Defects in the COG complex and COG-related trafficking regulators affect neuronal Golgi function.

Frontiers in neuroscience
2015

MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis.

Proteomics. Clinical applications

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Defeito no complexo de Golgi oligomérico conservado.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Defeito no complexo de Golgi oligomérico conservado

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function.
    PLoS genetics· 2026· PMID 41824529mais citado
  2. The COG3 subunit interacts with SNX1 to enhance salt tolerance in Arabidopsis.
    Plant physiology and biochemistry : PPB· 2026· PMID 41448066mais citado
  3. Identification of an ERGIC-Like Compartment in Fission Yeast: Emp43 Functions as a Lectin-Like Cargo Receptor for Glycosylated Proteins.
    Molecular microbiology· 2026· PMID 41203586mais citado
  4. Killer toxin K28 resistance in yeast relies on COG complex-mediated trafficking of the defence factor Ktd1.
    Journal of cell science· 2025· PMID 40557545mais citado
  5. Deep proteomic profiling of the intra-Golgi trafficking intermediates.
    Molecular biology of the cell· 2025· PMID 40397568mais citado
  6. Mast cell mediators in hereditary angioedema.
    Orphanet J Rare Dis· 2026· PMID 41832580recente
  7. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  8. Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis· 2026· PMID 41827036recente
  9. The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
    Orphanet J Rare Dis· 2026· PMID 41821052recente
  10. Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.
    Orphanet J Rare Dis· 2026· PMID 41821046recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309568(Orphanet)
  2. MONDO:0017750(MONDO)
  3. GARD:21344(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55787326(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Defeito no complexo de Golgi oligomérico conservado
Compêndio · Raras BR

Defeito no complexo de Golgi oligomérico conservado

ORPHA:309568 · MONDO:0017750
MedGen
UMLS
C5679953
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades